It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Thank you.
Some features of ATS will be disabled while you continue to use an ad-blocker.
A new large-scale peer-reviewed study shows that regular use of ivermectin reduces the risk of dying from COVID-19 by 92 percent. Hospital admissions even fell by 100 percent.
The large study was conducted by Flávio A. Cadegiani, MD, MSc, PhD. Cadegiani is a board-certified endocrinologist with a master's degree and a doctorate in clinical endocrinology.
The peer-reviewed study was published Wednesday by the online medical journal Cureus. The study was conducted on a strictly controlled population of 88,012 people from the city of Itajaí in Brazil and is the largest study of its kind, giving the findings a high degree of certainty.
The authors used a technique called propensity score matching to control for influencing factors that might otherwise have biased the study in one direction or the other. For example, those who took ivermectin were older than those who didn't (mean age 47 years versus 40 years), but matching people of similar age in each group and comparing the outcomes brought this confounding factor under control.
originally posted by: AaarghZombies
originally posted by: lordcomac
We know it does, that's why it was all but outlawed in the USA.
It was cutting into big pharm profits.
What big pharma gain in selling the vax they list 10 times over through a fall in the sale of things like cosmetics.
originally posted by: AaarghZombies
originally posted by: lordcomac
We know it does, that's why it was all but outlawed in the USA.
It was cutting into big pharm profits.
What big pharma gain in selling the vax they list 10 times over through a fall in the sale of things like cosmetics.
originally posted by: AaarghZombies
originally posted by: lordcomac
We know it does, that's why it was all but outlawed in the USA.
It was cutting into big pharm profits.
What big pharma gain in selling the vax they list 10 times over through a fall in the sale of things like cosmetics.